Analytical Data
-
Gene name
CKLFSF3
- Application
-
Alternative Names
Ckb; Ckbb; Creatine kinase B-type; EC 2.7.3.2; B-CK; Creatine kinase B chain; Creatine phosphokinase M-type; CPK-B
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P07335
-
Expression Region
1-182aa
-
AA Sequence
MWPPDPDPDPDPEPAGGSRPGPAVPGLRALLPARAFLCSLKGRLLLAESGLSFITFICYVASSASAFLTAPLLEFLLALYFLFADAMQLNDKWQGLCWPMMDFLRCVTAALIYFAISITAIAKYSDGASKAAGVFGFFATIVFATDFYLIFNDVAKFLKQGDSADETTAHKTEEENSDSDSD
-
Molecular Weight
45.76 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CKLFSF3 is a member of the CKLF (Chemokine-Like Factor) family, which plays significant roles in the immune system and cellular signaling. This recombinant protein has garnered attention due to its potential involvement in various physiological processes, including immune response modulation and inflammation. Previous studies have indicated that CKLFSF3 may interact with specific receptors and influence the migration and activation of immune cells. Understanding the structure and function of CKLFSF3 is critical for elucidating its biological roles and therapeutic potential. Given the rising interest in chemokine-like factors as targets for drug development, research on CKLFSF3 aims to explore its mechanisms of action, interactions with signaling pathways, and possible implications in diseases such as cancer and autoimmune disorders. Advances in recombinant DNA technology facilitate the production of CKLFSF3, enabling detailed functional analyses and high-throughput screening for potential inhibitors or modulators. Ultimately, the study of CKLFSF3 could unveil novel insights into immune regulation and lead to innovative strategies for therapeutic interventions.
